Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACCeNT-CP: AlloCB and hCT-MSC for Cerebral Palsy
NCT03473301Phase 2Completed
- Sponsor
- Joanne Kurtzberg
- Start
- Apr 2018
- Primary completion
- Feb 2020
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of allogeneic human umbilical cord blood, human umbilical cord tissue-derived mesenchymal stromal cells in cerebral palsy (CP), sponsored by Joanne Kurtzberg. Started Apr 2018; status: completed.
02
Drugs
allogeneic human umbilical cord bloodhuman umbilical cord tissue-derived mesenchymal stromal cells
03
Conditions
cerebral palsy (CP)
Beyond the preview
Go deeper on NCT03473301.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03473301.